Abstract

Thyroid cancer is among the most common cancer in women and new cases continue to rise in the entire world. There is a rarer subset of thyroid cancer as papillary microcarcinoma (black ink) that even small is aggressive and there is the need to early diagnosis to avoid their insidious behaviour. The incidence of this cancer is kept under control mostly by surgery. The current issue comprises of the fusion three articles pertaining to the development and validation of a standard method for investigated the utility of the Ultrasonography with BRAF mutation testing of thyroid fine-needle aspiration cytology specimens for the risk papillary thyroid microcarcinoma (PTMC).